OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
Bilal Rah, Rafiq A. Rather, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 132

Showing 26-50 of 132 citing articles:

Deciphering the anticancer potential of thymoquinone: in-depth exploration of the potent flavonoid from Nigella sativa
Bunty Sharma, Himanshu Shekhar, Anidrisha Sahu, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Immune Gene Signature as a Predictor of CDK4/6 Inhibitor Response in HR+/HER2– Breast Cancer
Eudald Felip, Edurne García-Vidal, Sara Cabrero-de las Heras, et al.
Research Square (Research Square) (2025)
Closed Access

STAT Signature Dish: Serving Immunity with a Side of Dietary Control
Hozaifa Metwally
Biomolecules (2025) Vol. 15, Iss. 4, pp. 487-487
Open Access

STAT3 Signaling Pathway in Health and Disease
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access

Unveiling the Role of JAK2/STAT3 Signaling in Chemoresistance of Gynecological Cancers: From Mechanisms to Therapeutic Implications
Tianxiao Zhang, Chang Xiaohan
Critical Reviews in Oncology/Hematology (2025), pp. 104712-104712
Closed Access

Molecular mechanisms of microRNA-216a during tumor progression
Amir Abbas Hamidi, Negin Taghehchian, Amir Sadra Zangouei, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12

Antitumor mechanism of cannabidiol hidden behind cancer hallmarks
Chaobiao Yan, Li Yu, Hanqing Liu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188905-188905
Closed Access | Times Cited: 12

Imidazopyridine-based kinase inhibitors as potential anticancer agents: A review
Fariba Peytam, Zahra Emamgholipour, Ali Mousavi, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106831-106831
Closed Access | Times Cited: 12

Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers
Arefeh Zabeti Touchaei, Sogand Vahidi, Ali Akbar Samadani
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4

Molecular pathways and targeted therapies in head and neck cancers pathogenesis
Marian Constantin, Mariana Carmen Chifiriuc, Coralia Bleoţu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4

An In Silico Approach to Uncover Selective JAK1 Inhibitors for Breast Cancer from Life Chemicals Database
Sruthy Sathish, Honglae Sohn, Thirumurthy Madhavan
Applied Biochemistry and Biotechnology (2025)
Closed Access

A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer
Sungjin David Park, Apryl S. Saunders, Megan A. Reidy, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17

Selenoprotein S: A versatile disordered protein
Farid Ghelichkhani, Fabio González, Mariia A. Kapitonova, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 731, pp. 109427-109427
Open Access | Times Cited: 16

REST Targets JAK–STAT and HIF-1 Signaling Pathways in Human Down Syndrome Brain and Neural Cells
Tan Huang, Sharida Fakurazi, Pike-See Cheah, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9980-9980
Open Access | Times Cited: 10

Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19
Aroona Razzaq, Cyrollah Disoma, Yuzheng Zhou, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 10

Developments in Genetics – a Better Management of Ovarian Cancer Patients
Ovidiu Maioru, Viorica Rădoi, Laurențiu Camil Bohîlțea, et al.
(2023)
Open Access | Times Cited: 9

Upregulation of EMR1 (ADGRE1) by Tumor-Associated Macrophages Promotes Colon Cancer Progression by Activating the JAK2/STAT1,3 Signaling Pathway in Tumor Cells
Rokeya Akter, Rackhyun Park, Soo‐Kyung Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4388-4388
Open Access | Times Cited: 3

Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies
Anna Wolska, Piotr Smolewski
Cancers (2022) Vol. 14, Iss. 15, pp. 3778-3778
Open Access | Times Cited: 15

The role of JAK/STAT signaling pathway in cerebral ischemia-reperfusion injury and the therapeutic effect of traditional Chinese medicine: A narrative review
Tianzhi Song, Yishu Zhang, Zhu Liangrong, et al.
Medicine (2023) Vol. 102, Iss. 46, pp. e35890-e35890
Open Access | Times Cited: 7

Genome-wide p63-target gene analyses reveal TAp63/NRF2-dependent oxidative stress responses
Marco Napoli, Avani A. Deshpande, Deepavali Chakravarti, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 264-278
Open Access | Times Cited: 2

Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets
Yuezhen Liu, Bing Jiang, Yanqiang Li, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36467-e36467
Open Access | Times Cited: 2

Scroll to top